The Centre has provided financial assistance within the sort of a grant of Rs 220 crore to vaccine manufacturers to spice up the assembly of Bharat Biotech’s COVID-19 vaccine Covaxin, and its production is predicted to succeed in quite 10 crore doses per month by September this year.
The Department of Biotechnology, which is implementing Mission COVID Suraksha announced as a part of Atmanirbhar Bharat 3.0 to accelerate development and production of indigenous COVID-19 vaccines, has provided financial assistance to vaccine manufacturers, the Ministry of Science & Technology said during a statement.
“As a neighborhood of this augmentation plan, capacities of Bharat Biotech Limited, Hyderabad also as other public sector manufactures are being upgraded with required infrastructure and technology. support is being provided as a grant from the govt of India (GoI) to the tune of roughly Rs 65 crore to Bharat Biotech’s new Bangalore facility which is being repurposed to extend the capacity of vaccine production,” the statement said.
Among the general public sector companies, Mumbai-based Haffkine Biopharmaceutical Corporation Ltd, a public sector enterprise under the Maharashtra government, has been provided a grant of Rs 65 crore for manufacturing Covaxin. Once functional, it’ll have a capacity to supply 2 crore doses per month.
“Indian Immunologicals Limited (IIL), Hyderabad, a facility under National Dairy Development Board, is being provided a grant of Rs 60 crore and…Bharat Immunologicals and Biologicals Limited (BIBCOL), Bulandshahr, a CPSE under Department of Biotechnology, Government of India, is being supported with a grant of Rs 30 crore to organize their facility to supply 10-15 million doses per month,” it said.
Besides, Gujarat Biotechnology Research Centre, under the Gujarat government, alongside Hester Biosciences and OmniBRx, has also firmed up its discussions with Bharat Biotech to proportion Covaxin production and produce a minimum of two crore doses per month. The technology transfer agreement has been finalised with all manufacturers, the statement said.
Amidst the second wave of COVID-19 pandemic and therefore the opening from COVID-19 vaccination for everybody above 18 years aged within the country, there’s a shortage of vaccines within the country. However, the Centre expects the supply of vaccines to enhance from July and plans to inoculate the whole adult population of roughly 95 crores by this December.
The country has administered 18.14 crore doses of COVID-19 vaccines thus far.